ELOVL1 and hepatocellular carcinoma: In the context of hepatocellular carcinoma (HCC), ELOVL1 appears to influence immune cell infiltration and the expression of immune checkpoint markers, such as programmed cell death-1 (PD-1) and cytotoxic T lymphocyte-associated protein-4 (CTLA-4) [69].